Profile data is unavailable for this security.
About the company
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
- Revenue in NOK (TTM)0.00
- Net income in NOK-40.10m
- Incorporated2012
- Employees8.00
- LocationExact Therapeutics ASOstre Aker vei 19OSLO 0581NorwayNOR
- Websitehttps://www.exact-tx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovica International AB | 3.94m | -93.35m | 275.20m | 33.00 | -- | 1.80 | -- | 69.80 | -2.81 | -2.81 | 0.1169 | 3.82 | 0.0216 | -1.67 | 8.55 | 155,160.00 | -51.17 | -30.85 | -55.61 | -33.47 | 152.10 | 332.81 | -2,367.83 | -1,470.09 | 8.35 | -543.41 | 0.0592 | -- | -1.54 | 26.47 | -51.97 | -- | -- | -- |
| SenzaGen AB | 42.45m | -25.32m | 276.39m | 16.00 | -- | 3.05 | -- | 6.51 | -1.03 | -1.03 | 1.73 | 3.71 | 0.3292 | 4.24 | 4.56 | -- | -19.63 | -25.18 | -24.68 | -27.95 | 65.44 | 78.89 | -59.64 | -214.33 | 1.86 | -- | 0.0133 | -- | 170.85 | 105.03 | 20.53 | -- | -29.85 | -- |
| Arctic Bioscience AS | 34.27m | -34.02m | 279.07m | -- | -- | 0.9334 | -- | 8.14 | -1.40 | -1.40 | 1.41 | 11.79 | 0.1024 | 0.7072 | 3.24 | -- | -10.17 | -- | -11.20 | -- | 33.98 | -- | -99.28 | -- | 4.03 | -- | 0.00 | -- | 59.29 | -- | 20.09 | -- | -- | -- |
| Opticept Technologies AB | 11.65m | -107.99m | 314.99m | -- | -- | 0.818 | -- | 27.03 | -5.26 | -5.26 | 0.5134 | 12.69 | 0.0273 | 0.5937 | 2.14 | -- | -25.20 | -44.86 | -27.03 | -49.01 | -6.06 | 42.23 | -922.44 | -863.20 | 1.45 | -11.15 | 0.0593 | -- | 136.46 | 122.77 | -112.89 | -- | 35.79 | -- |
| Corline Biomedical AB | 28.33m | 4.27m | 327.64m | 8.00 | 76.76 | 3.37 | 75.55 | 11.56 | 0.1954 | 0.1954 | 1.30 | 4.45 | 0.2778 | -- | 9.88 | -- | 4.18 | -7.76 | 4.49 | -8.58 | 99.92 | 151.14 | 15.07 | -76.39 | -- | -- | 0.00 | -- | 233.47 | 105.79 | 133.65 | -- | 12.38 | -- |
| Exact Therapeutics AS | 0.00 | -40.10m | 329.97m | 8.00 | -- | 5.07 | -- | -- | -1.34 | -1.34 | 0.00 | 2.17 | -- | -- | -- | -- | -- | -28.38 | -- | -32.26 | -- | -- | -- | -- | -- | -- | 0.0252 | -- | -- | -- | -- | -- | -- | -- |
| InDex Pharmaceuticals Holding AB | 0.00 | -125.26m | 342.17m | 6.00 | -- | 1.15 | -- | -- | -0.2314 | -0.2314 | 0.00 | 0.5486 | 0.00 | -- | -- | 0.00 | -32.62 | -44.83 | -34.71 | -49.19 | -- | -17,889.64 | -- | -171,599.60 | -- | -- | 0.0103 | -- | -- | -- | 2.63 | -- | -- | -- |
| Magle Chemoswed Holding AB | 156.62m | 9.30m | 351.26m | -- | 37.78 | 2.31 | 15.55 | 2.24 | 0.847 | 0.847 | 14.27 | 13.85 | 0.5851 | 0.4335 | 7.68 | -- | 3.47 | 1.26 | 4.64 | 1.96 | 92.04 | 84.89 | 5.94 | 1.95 | 0.7218 | 4.97 | 0.2851 | -- | 10.24 | 5.27 | 113.77 | 15.62 | -2.18 | -- |
| Vo2 Cap Holding AB (publ) | 463.51m | 11.18m | 352.23m | -- | 31.81 | 1.64 | 6.88 | 0.7599 | 0.2037 | 0.2037 | 8.66 | 3.96 | 1.22 | -- | 8.77 | -- | 2.95 | -4.47 | 4.06 | -6.80 | 30.20 | 24.67 | 2.41 | -3.45 | -- | 5.76 | 0.2007 | -- | 59.92 | 113.75 | 224.08 | -- | 50.38 | -- |
| Alligator Bioscience AB | 40.59m | -216.36m | 359.84m | 58.00 | -- | 7.36 | -- | 8.87 | -0.5849 | -0.5849 | 0.1097 | 0.0727 | 0.1915 | -- | 4.45 | 753,452.80 | -102.08 | -49.02 | -144.73 | -55.65 | -- | -- | -533.07 | -994.67 | -- | -563.72 | 0.4679 | -- | 175.79 | -8.90 | -36.45 | -- | -50.08 | -- |
| INIFY Laboratories AB | 0.00 | -51.06m | 360.93m | -- | -- | 2.85 | -- | -- | -1.42 | -1.42 | 0.00 | 2.80 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Orexo AB | 633.82m | -221.57m | 366.90m | 122.00 | -- | 2.77 | -- | 0.5789 | -6.34 | -6.34 | 18.15 | 3.76 | 0.5788 | 1.46 | 2.29 | 4,949,207.00 | -20.22 | -2.02 | -28.86 | -3.17 | 83.35 | 84.93 | -34.94 | -3.69 | 1.72 | -- | 0.8417 | -- | 10.50 | -0.6102 | 20.54 | -- | 71.73 | -- |
| Lytix Biopharma AS | 1.41m | -60.45m | 368.63m | -- | -- | 3.16 | -- | 261.62 | -1.45 | -1.45 | 0.0349 | 2.91 | 0.0088 | -- | 0.1969 | -- | -37.60 | -58.54 | -41.51 | -71.35 | -- | -- | -4,290.14 | -11,603.32 | -- | -- | 0.00 | -- | 8,188.24 | 5.88 | -16.56 | -- | -- | -- |
| Herantis Pharma Oyj | 0.00 | -110.25m | 379.96m | -- | -- | -- | -- | -- | -0.6758 | -0.6758 | 0.00 | -0.0036 | 0.00 | -- | -- | -- | -133.26 | -84.65 | -196.74 | -106.59 | -- | -- | -- | -- | -- | -6.00 | 1.01 | -- | -- | -- | 26.97 | -- | -- | -- |
| Initiator Pharma A/S | 0.00 | -51.63m | 382.53m | -- | -- | 9.76 | -- | -- | -1.01 | -1.01 | 0.00 | 0.7374 | 0.00 | -- | -- | -- | -84.78 | -68.41 | -92.84 | -75.18 | -- | -- | -- | -- | -- | -- | 0.3392 | -- | -- | -- | -82.56 | -- | -- | -- |
| AlzeCure Pharma AB | 0.00 | -54.01m | 383.67m | 12.00 | -- | 7.41 | -- | -- | -1.01 | -1.01 | 0.00 | 0.821 | 0.00 | -- | -- | 0.00 | -79.59 | -44.86 | -94.34 | -47.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27.70 | -- | -- | -- |
Data as of Jun 05 2023. Currency figures normalised to Exact Therapeutics AS's reporting currency: Norwegian Krone NOK
6.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management AB (Norway)as of 28 Feb 2023 | 1.24m | 4.15% |
| Danske Invest Asset Management ASas of 31 May 2023 | 590.75k | 1.97% |
Data from 28 Apr 2023 - 31 May 2023Source: FactSet Research Systems Inc.
